Japan endoscopy market to grow 4% CAGR as robotic-assisted procedures expand

Rising gastrointestinal cancer cases are increasing demand for endoscopy procedures.

Japan’s endoscopy market is expected to grow steadily at a 4% compound annual growth rate through 2036, driven by rising gastrointestinal (GI) cancer cases and increasing demand for minimally invasive procedures, according to GlobalData.

The report noted that growing clinical preference for minimally invasive GI treatments, along with rapid technological improvements in endotherapy systems, is accelerating adoption across major healthcare markets.

In line with this trend, Japan’s Olympus has signed a global distribution agreement with South Korea’s EndoRobotics to expand its robotic-assisted endoscopy capabilities. The partnership will support advanced procedures such as endoscopic submucosal dissection (ESD), aiming to improve precision and efficiency in complex minimally invasive treatments.

Anindita Ghosh, medical devices analyst at GlobalData, said robotic-assisted endoscopy marks a significant step forward in gastrointestinal care.

“As healthcare providers increasingly prioritize precision-driven and organ-preserving treatment approaches, collaborations such as the Olympus-EndoRobotics agreement are expected to accelerate adoption of advanced endoscopic procedures globally,” she said.

She added that adoption will depend on reimbursement systems, training availability, and regulatory pathways, but ongoing innovation and industry collaborations are expected to drive broader use in the coming years.

“Robot-assisted therapeutic endoscopy technologies are expected to play an increasingly important role in the future of gastrointestinal disease management,” she said.